OP-028 Comparision of Effects of Rosuvastatin Versus Atorvastatin Treatment on Plasma Levels of Asymmetric Dimethylarginine in Hyperlipidemic Patients with Coronary Artery Disease




Objective


Elevated plasma levels of asymmetric dimethylarginine (ADMA) are prevalent in patients with hypercholesterolemia and coronary artery disease. We evaluated the effect of a moderate dose of rosuvastatin with that of atorvastatin on plasma levels of ADMA in hypercholesterolemic patients with mild coronary artery stenosis.




Methods


Eighty-three patients with hypercholesterolemia and angiographically documented mild coronary artery stenosis were randomized to rosuvastatin treatment (20 mg) or atorvastatin treatment (40 mg) once daily for 6 weeks after a 4-week dietary lead-in phase. Plasma ADMA levels were measured by an ELISA method. Plasma lipid parameters were measured by standard methods.

Only gold members can continue reading. Log In or Register to continue

Related posts:

  1. OP-008 Evaluation of Effectiveness and Safety of Everolimus Eluting Stent System (XIENCE V) in Patients with Atrial Fibrillation
  2. OP-021 Atrial Electromechanical Delay Detected by Tissue Doppler Imaging is associated with the Postoperative Atrial Fibrillation After Coronary Artery Bypass Surgery
  3. OP-029 Job Stress as Risk Factor of Long-Term Risk of Myocardial Infarction in Female Population Aged 25-64 Years in Russia (Based on Who Epidemiological Program “Monica-Psychosocial”)
  4. OP-086 New Modified Balloon-Assisted Technique to Provide Appropriate Deployment in the Closure of Large Secundum Atrial Septal Defect Using Amplatzer Septal Occluder

Stay updated, free articles. Join our Telegram channel
Tags:
Dec 1, 2016 | Posted by in CARDIOLOGY | Comments Off on OP-028 Comparision of Effects of Rosuvastatin Versus Atorvastatin Treatment on Plasma Levels of Asymmetric Dimethylarginine in Hyperlipidemic Patients with Coronary Artery Disease

Full access? Get Clinical Tree
Get Clinical Tree app for offline access